← Back to Search

Anti-androgen

VERU-100 for Prostate Cancer (VERU-100 Trial)

Q: How many potential participants are being asked to join this clinical trial?

To run this trial, the organisers require 40 individuals who meet specific conditions. These patients must visit one of the participating locations, such as <a href="https://www.withpower.com/clinical-trials/arizona">Arizona</a> Urology Specialists, PLLC in Glendale or Genesis Research, LLC in San Diego.

Q: In how many different cities is this medical study being conducted?

There are 21 sites currently running this study. The locations are located in Glendale, San Diego and Jeffersonville to name a few other locations. It is important to select the location closest you to minimize travel requirements if you participate.

Q: Is it possible to sign up for this clinical trial at the moment?

According to information available on clinicaltrials.gov, this trial is still open for recruitment and was last updated on 10/11/2022. The original posting date was 6/9/2021. Presently, the study is looking for 40 individuals across 21 different sites.

Q: Are minors welcome in this clinical trial?

From the information available, it seems that people aged 18 to 100 are eligible for this trial. Out of the 786 trials happening currently, only 7 involve patients who are below eighteen years old.

Q: To whom does this study's eligibility criteria apply?

We are currently enrolling up to 40 patients that have adenocarcinoma and meet the age requirement of being over 18. The most important eligibility criteria are as follows: good communication with study personnel, a QTc interval &#x3C;440 ms, a doctor's assessment that the subject is a candidate for androgen deprivation therapy, an ECOG performance status of 0-2, and a life expectancy of at least 18 months.

Phase 1 & 2

Waitlist Available

Research Sponsored by Veru Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 28 and day 91

Awards & highlights

VERU-100 Trial Summary

This trial will test the feasibility of using VERU-100 to lower testosterone levels in men with advanced prostate cancer.

Eligible Conditions

Prostate Cancer

VERU-100 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 28 and day 91

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 28 and day 91

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 28 and day 91 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of men with total testosterone at <50 ng/dL by day 28

Secondary outcome measures

Total testosterone below 20ng/dL levels on VERU-100

VERU-100 Trial Design

1Treatment groups

Experimental Treatment

Group I: VERU-100 at various dosesExperimental Treatment1 Intervention

2 ml, 2.5 ml, 3 ml, 3.5 ml of VERU-100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Veru Inc.Lead Sponsor

10 Previous Clinical Trials

668 Total Patients Enrolled

BernetteStudy ChairVeru Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many potential participants are being asked to join this clinical trial?

"To run this trial, the organisers require 40 individuals who meet specific conditions. These patients must visit one of the participating locations, such as Arizona Urology Specialists, PLLC in Glendale or Genesis Research, LLC in San Diego."

Answered by AI

In how many different cities is this medical study being conducted?

"There are 21 sites currently running this study. The locations are located in Glendale, San Diego and Jeffersonville to name a few other locations. It is important to select the location closest you to minimize travel requirements if you participate."

Answered by AI

Is it possible to sign up for this clinical trial at the moment?

"According to information available on clinicaltrials.gov, this trial is still open for recruitment and was last updated on 10/11/2022. The original posting date was 6/9/2021. Presently, the study is looking for 40 individuals across 21 different sites."

Answered by AI

Are minors welcome in this clinical trial?

"From the information available, it seems that people aged 18 to 100 are eligible for this trial. Out of the 786 trials happening currently, only 7 involve patients who are below eighteen years old."

Answered by AI

To whom does this study's eligibility criteria apply?

"We are currently enrolling up to 40 patients that have adenocarcinoma and meet the age requirement of being over 18. The most important eligibility criteria are as follows: good communication with study personnel, a QTc interval <440 ms, a doctor's assessment that the subject is a candidate for androgen deprivation therapy, an ECOG performance status of 0-2, and a life expectancy of at least 18 months."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

2021. "To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04843319.